Mad Money w/ Jim Cramer 11/17/23
Mad Money w/ Jim Cramer
CNBC
4.3 • 4K Ratings
🗓️ 18 November 2023
⏱️ 40 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | My mission is simple, to make you money. |
| 0:04.0 | I'm here to level the playing field for all investors. |
| 0:08.0 | There's always a homework somewhere, |
| 0:10.0 | and I promise to help you find it. |
| 0:12.0 | Man money starts now. |
| 0:14.0 | Hey, I'm Kramer. |
| 0:18.0 | Welcome to Mad Money. |
| 0:19.0 | Welcome to Cray America. |
| 0:21.0 | If people want to make friends, |
| 0:22.0 | I'm just trying to make you some money. My job |
| 0:24.7 | is not just entertained, but to educate and teach you. So call me at 1-807,000, 743 CBC, or tweet me at Jim Kramer. Some things changed. The market is, for lack of a more poetic term, better! |
| 0:38.0 | The cynics and the naysayers, they've been stunned, at least momentarily, it's plain old ordinary stock being |
| 0:45.0 | making a comeback. Long ignored household names are emerging from the shadow of |
| 0:48.8 | the Magnificent Seven and their stocks are making you money again after a long hiatus. |
| 0:54.3 | That's the story today, even if the broader average did next to nothing, |
| 0:57.7 | down creeping up two points, S&B advancing 0.13%, |
| 1:00.1 | 9, that's that ginching up 0.8%. |
| 1:02.3 | How this happened? This C change. Interest rates, that's how. As long as |
| 1:07.4 | longer-term buying yields were going up and we knew they were going up, you had to stick |
| 1:11.0 | with companies that exceptional growth matter what interest |
| 1:13.6 | did, meaning usually tech and drugs. Somehow because the pharmaceutical industry is so |
| 1:18.3 | stultified, the drug companies failed to deliver. That left tech is the loan standard |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

